Truist Financial
OCUL icon

Truist Financial’s Ocular Therapeutix OCUL Stock Holding History

Truist Financial’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.19M Hold
121,000
– – ﹤0.01% 1660
2026
Q1 		$1.02M Buy
121,000
+21,000
+21% +$200K ﹤0.01% 1689
2025
Q4 		$1.21M Hold
100,000
– – ﹤0.01% 1562
2025
Q3 		$1.17M Hold
100,000
– – ﹤0.01% 1592
2025
Q2 		$928K Buy
100,000
+50,000
+100% +$391K ﹤0.01% 1633
2025
Q1 		$367K Hold
50,000
– – ﹤0.01% 2046
2024
Q4 		$427K Buy
+50,000
New +$488K ﹤0.01% 1970

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Truist Financial's OCUL Position: Q2 2026 in Review

Truist Financial held its Ocular Therapeutix (OCUL) position steady in Q2 2026 at 121,000 shares worth $1.19M. The position accounts for ﹤0.01% of the portfolio, ranked #1660.

Truist Financial first reported a position in OCUL in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.21M in Q4 2025. 262 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

  • Truist Financial held 121,000 shares of Ocular Therapeutix worth $1.19M as of Q2 2026.
  • Truist Financial left its Ocular Therapeutix share count unchanged in Q2 2026.
  • Ocular Therapeutix made up ﹤0.01% of Truist Financial's portfolio in Q2 2026, its #1660 holding.
  • Truist Financial first reported a position in Ocular Therapeutix in Q4 2024 and has held it in 7 quarters since.
  • Truist Financial's Ocular Therapeutix position peaked at $1.21M in Q4 2025.
  • 262 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.